This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Heart Transplant Research Transplant 
Medical Xpress - Cardiology
JANUARY 3, 2024
The world's first partial heart transplant has achieved what researchers have spent more than a year hoping for—functioning valves and arteries that grow along with the young patient, as hypothesized by the pioneering team behind the procedure at Duke Health.
105 
Becker's Hospital Review - Cardiology
JULY 24, 2024
Discover the innovative device developed by Tampa General Hospital researchers that extends the viability of transplant hearts by three hours
59 
Becker's Hospital Review - Cardiology
MARCH 18, 2024
Philadelphia-based University of Pennsylvania researchers found the number of heart transplant emergency department visits increased with high admission rates but low in-hospital mortality rates.
Becker's Hospital Review - Cardiology
MAY 28, 2024
Researchers at Atlanta-based Emory University developed artificial intelligence that they say improves the prediction of successful heart transplants by 10%.
Medical Xpress - Cardiology
NOVEMBER 4, 2024
When a patient with heart failure has received a new heart and survives—the transplantation is deemed a success. However, health care overlooks heart recipients who suffer from long-term and often severe symptoms, such as pain and fatigue.
45 
Becker's Hospital Review - Cardiology
FEBRUARY 16, 2024
When patients awaiting crucial heart transplants are placed on the organ transplant waiting list, they've traditionally been arranged based on what type of treatments they were receiving for their current condition. But researchers from the University of Chicago have discovered a new, more accurate way to rank patients.
DAIC
JULY 3, 2024
Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions. Kobashigawa was instrumental in expanding the Comprehensive Transplant Program at Cedars-Sinai , one of the largest transplant programs in the world. “Dr.
105 
Medical Xpress - Cardiology
AUGUST 16, 2024
The risk of early heart failure after heart transplantation is lower if the donor heart is stored in a so-called heart-in-a-box instead of in the usual cooler with ice. This is according to a study by researchers at the University of Gothenburg.
89 
Journal of Cardiothoracic Surgery
FEBRUARY 9, 2024
Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.
DAIC
FEBRUARY 13, 2024
THE TEXAS HEART INSTITUTE 2024 milla1cf Tue, 02/13/2024 - 17:56 February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. The research, led by esteemed physician-scientist at The Texas Heart Institute ( THI ), Dr. James F.
111 
Cardiovascular Diabetology
JUNE 20, 2024
Pretransplant type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular and all-cause mortality after heart transplant (HT), but the underlying causes of this association remain unclear.
Science Daily - Heart Disease
JUNE 10, 2024
Having explored how the heart is formed in utero, a researcher is reporting how cells and molecules act during that early formation and what might cause the heart disease called left ventricular non-compaction or spongy heart, for which patients often require heart transplants.
Med Page Today
FEBRUARY 13, 2024
(MedPage Today) -- To more fairly rank candidates for heart transplant, researchers developed the U.S. candidate risk score (US-CRS) and found it to better discriminate risk for people with advanced heart failure than the current six-status system.
DAIC
FEBRUARY 21, 2024
As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.
105 
Cardiology Update
APRIL 25, 2024
RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.
DAIC
APRIL 30, 2024
Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.
105 
Heart 2023 Conference
JANUARY 17, 2024
Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute. This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions.
DAIC
FEBRUARY 22, 2024
Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early.
104 
Journal of Cardiothoracic Surgery
FEBRUARY 15, 2024
This study investigates the efficacy of using a long-acting insulin analog, along with the infusion of regular insulin, in achieving appropriate glycemic control and correcting lactic acidosis in patients post.
Cardiology Update
JANUARY 22, 2024
The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. At a mean (±SD) follow-up of 40±20 months, CRT showed a significantly lower risk of death or hospitalization due to heart failure.
115 
European Journal of Heart Failure
DECEMBER 13, 2023
Abstract Aims There is uncertainty about the definition of iron deficiency (ID) and the association between ID and prognosis in patients with advanced heart failure. We evaluated three definitions of ID in patients referred for heart transplantation.
DAIC
DECEMBER 8, 2023
The study also includes a registry for advanced heart failure patients who are end stage and not considered to be surgical candidates for a heart transplant or left ventricular assist device (LVAD) implant due to excessive fluid retention and poor kidney function. Fain, MD , President and Chief Executive Officer, Procyrion. "We
113 
DAIC
APRIL 16, 2024
William Abraham of the Ohio State Wexner College of Medicine presented analysis showing that patients in the trial with Barostim + GDMT had a 74% reduced risk of receiving advanced heart failure interventions (transplant, LVAD, CCM, CRT or CardioMEMS) at long-term follow-up versus patients on GDMT alone. See more details at TCTMD.
104 
European Journal of Heart Failure
DECEMBER 13, 2023
CV, cardiovascular; HT, heart transplantation; ICU, intensive care unit; LVAD, left ventricular assist device. The primary endpoint was the rate of weaning from VA-ECMO during index admission. The early LV unloading strategy did not increase the weaning rate from VA-ECMO compared with the conventional approach.
75 
DAIC
MARCH 13, 2024
The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by CMS for both treatment and control procedures. The study includes an eligibility requirement that patients demonstrate a pre-specified NT-proBNP level at baseline.
111 
Society of Thoracic Surgeons - Technology
JANUARY 19, 2022
With her fellowship, Dr. Fiedler plans to learn skills and administrative approaches that will help her expand the heart transplant program at UW-Madison, where she currently serves as associate director of heart transplantation and mechanical circulatory support. For more information, visit sts.org.
DAIC
APRIL 6, 2024
While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.
Open Heart
MAY 25, 2022
The secondary outcome was the TE and mortality and heart transplantation rates between paediatric and adult patients with LVNC. Studies that did not present original research, non-human studies, duplicated studies were excluded. Methods The primary outcome was the prevalence and incidence of TE in the patients with LVNC.
DAIC
APRIL 6, 2024
While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.
European Journal of Heart Failure
NOVEMBER 9, 2023
The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. The secondary endpoint was first heart failure admission. Multivariable Cox regression and propensity score matching (PSM) analyses were performed.
40 European Journal of Heart Failure
OCTOBER 3, 2023
CV mortality is the composite endpoint for CV mortality + urgent transplant + left ventricular assist device implantation. Abstract Aims Improvement of left ventricular ejection fraction is a major goal of heart failure (HF) treatment. Events per 1000 person-years. # ml/min, peak oxygen uptake 62.2
MIBHS
SEPTEMBER 30, 2024
Open-Heart Surgery : In cases where catheterization is not sufficient, open-heart surgery may be required to repair the defect. This involves opening the chest and heart to make the necessary repairs. Heart Transplant : In the most severe cases, where the heart is too damaged to be repaired, a heart transplant may be necessary.
52 
European Journal of Heart Failure
DECEMBER 13, 2023
For the global rank score all participants were ranked across three hierarchical groups: Tier 1 = time to death or urgent heart transplantation or implantation of a ventricular assist device; Tier 2 = time to non-fatal HF requiring i.v.
DAIC
APRIL 8, 2024
Researchers randomly assigned patients to receive standard care or standard care plus treatment with an Impella CP pump. of those who received the Impella pump had died at six months after randomization; there was a 13 percentage point absolute reduction in the rate of death, the study’s primary endpoint, in favor of the heart pump.
52 Circulation: Heart Failure
FEBRUARY 20, 2024
Circulation: Heart Failure, Ahead of Print. Background:Black heart transplant patients are at higher risk of acute rejection (AR) and death than White patients. The incidence of AR was higher in Black patients compared with White patients (43% versus 19%;P=0.002). 5.04];P=0.004) and %dd-cfDNA (hazard ratio, 1.15 [95% CI, 1.03–1.28];P=0.010)
Dr. Anish Koka
JUNE 5, 2023
While US public health authorities have been convinced from the very beginning about how safe and effective the new vaccines are, researchers in other countries with far smaller budgets have been testing that theory. This identified eight cases of sudden cardiac death as caused by VRM that were not known until the autopsy was performed. .
52 
Cardiology Update
APRIL 9, 2024
The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. The primary superiority endpoint was clinically relevant bleeding (Bleeding Academic Research Consortium [known as BARC] types 2, 3, or 5).
DAIC
MARCH 6, 2024
Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. All rights reserved. 4 Fine, N.
105 
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.
52 
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.
52 
European Journal of Heart Failure
NOVEMBER 7, 2023
The composite endpoint consisted of all-cause mortality, aborted sudden cardiac death, major ventricular arrhythmic events, heart failure hospitalization and heart transplantation. A total of 319 CS patients were studied (67% male, 55.4 ± 12 years). During a median follow-up of 2.2 years
Cardiometabolic Health Congress
MARCH 8, 2024
There is increased cognizance of gender inequality and the importance of inclusive and diverse approaches to medical research. Historically, women have been underrepresented in scientific fields, and this spills over into the research and study of women’s health.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content